GSK-843 (GSK'843) is a novel and potent inhibitot of receptor-interacting protein kinase 3 (RIP3 or RIPK3) with anti-inflammatory effects. It binds RIP3 kinase domain with an IC50 of 8.6 nM, and inhibits kinase activity with an IC50 of 6.5 nM.